Doc code- IDS PTO/SB/OSa (OI-IO)
. ... , , 1- r-,- 1 c^t X X /ir>r.\ i-i j Approved for use thrDUoh 07/31/2012. OMB 0651-0031
Doc description. Information Disclosure Statement (IDS) Filed u.s. Patent and TraSema* office; u.s. department of commerce
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
INrOKIvlATlUN DISCLOSURE
STATEMENT BY APPLICANT
( Not for submission under 37 CFR 1.99)
Application Number
10551504
Filing Date
2006-05-12
First Named Inventor
Tsunoda et al.
Art Unit
1647
Examiner Name
Shulamith H. Shafer
Attorney Docket Number
14875-0153US1
U.S. PATENTS
Remove
Exanniner
Initial*
Cite
No
Patent Number
Kind
Codei
Issue Date
Name of Patentee or Applicant
of cited Document
Pages,Columns,Lines where
Relevant Passages or Relevant
Figures Appear
5618920
1997-04-08
ROBINSON etal.
5780021
1998-07-14
SOBEL
5977322
1999-11-02
MARKS etal.
6361760
2002-03-26
TOVEY
If you \N\5h to add additional U.S. Patent citation information please click the Add button.
Add
U.S. PATENT APPLICATION PUBLICATIONS
Remove
Examiner
initial*
Cite No
Publication
Number
Kind
Codei
Publication
Date
Name of Patentee or Applicant
of cited Document
Pages,Columns,Lines where
Relevant Passages or Relevant
Figures Appear
20090311718
2009-12-17
FUKUSHIMAetal.
20100092457
2010-04-15
ABU RATANI etal.
If you wish to add additional U.S. Published Application citation information please click the Add button. Add
FOREIGN PATENT DOCUMENTS
Remove
EFS Web 2.1.17
INFORMATION DISCLOSURE
STATEMENT BY APPLICANT
( Not for submission under 37 CFR 1.99)
Application Number
10551504
Filing Date
2006-05-12
First Named Inventor
Tsunoda et al.
Art Unit
1647
Examiner Name
Shulamith H. Shafer
Attorney Docket Number
14875-0153US1
Examiner
Initial*
Cite
No
Foreign Document
Number3
Country
Code2 j
Kind
Code4
Publication
Date
Name of Patentee or
Applicant of cited
Document
Pian^Q f^nliiiTinQ 1 in^Q
I Ciyc^O, WLflUI 1 II 19, ^11
where Relevant
Passages or Relevant
Figures Appear
T5
1
1870458
EP
2007-12-26
IGAWAetal.
□
2
1900814
EP
2008-03-19
IGAWAetal.
□
3
9100739
WO
1991-01-24
UENOetal.
□
If you wish to add additional Foreign Patent Document citation information please click the Add button
Add
NON-PATENT LITERATURE DOCUMENTS
Remove
Examiner
Initials*
Cite
No
Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
publisher, city and/or country where published.
T5
1
ARNDT et al., "Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment,"
Biochemistry. 37(37): 1291 8-26 (1998)
□
2
BROOKE et al., "Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory
protein (SIRP) family," J. Immunol., 173:2562-2570 (2004)
□
3
CHATELLIER et al., "Functional mapping of conserved residues located at the VL and VH domain interface of a Fab,"
J. Mol. Biol., 264(1):1-6 (1996)
□
4
CHOWDHURY et al., "Engineering scFvs for improved stability," Methods Mol. Biol., 207:237-54 (2003)
□
5
DAVIES et al., "Antibody VH domains as small recognition units," Biotechnology (N.Y.), 13(5):475-9 (1995)
□
EFS Web 2.1.17
INFORMATION DISCLOSURE
STATEMENT BY APPLICANT
( Not for submission under 37 CFR 1.99)
Application Number
10551504
Filing Date
2006-05-12
First Named Inventor
Tsunoda et al.
Art Unit
1647
Examiner Name
Shulamith H. Shafer
Attorney Docket Number
14875-0153US1
6
JUNG et al., "The Importance of framework residues H6, H7 and H10 In antibody heavy chains: experimental evidence
for a new structural subclasslflcatlon of antibody V(H) domains," J. Mol. Biol., 30g(3):701-16 (2001)
□
7
KAUSHANSKY, "Lineage-specific hematopoietic growth factors," N. Engl. J. Med., 354(1 9):2034-45 (2006)
□
8
KIHALIFA et al., "Effects on Interaction Idnetics of mutations at the VH-VL Interface of Fabs depend on the structural
context." J. Mol. Recognlt., 13(3):127-39 (2000)
□
9
VARGAS-MADRAZO et al., "An Improved model of association for VH-VL Immunoglobulin domains: asymmetries
between VIH and VL In the packing of some Interface residues," J. Mol. Recognit., 16(3):1 1 3-20 (2003)
□
10
VERNON-WILSON et al., "CD47 Is a llgand for rat macrophage membrane signal regulatory protein SIRP (OX41 ) and
human SIRPalpha 1," Eur. J. Immunol., 30:2130-2137 (2000)
□
11
WU et a!., "Multlmerization of a chimeric antl-CD20 single-chain Fv-Fc fusion protein Is mediated through variable
domain exchange," Protein Eng., 14(1 2): 1025-33 (2001)
□
12
U.S. EXAMINER LYNN ANNE BRISTOL, USPTO Final Office Action In U.S. App. Ser. No. 10/560,098, mailed
June 3, 2010, 16 pages
□
13
FISH & RICHARDSON P.O., Amendment In Reply to Action dated January 25, 2010 In U.S. App. Ser. No. 10/582,176,
filed July 23, 2010, 1 1 pages
□
14
FISH & RICHARDSON P.C., Amendment In Reply to Action dated March 24, 2010 In U.S. App. Ser. No. 10/582,304,
filed July 26, 2010, 14 pages
□
15
FISH & RICHARDSON P.C., Amendment In Reply to Action dated Febmary 19, 2010 In U.S. App. Ser.
No. 11/547,747, filed June 18, 2010, 13 pages
□
16
European Search Report for App. Ser. No. EP 06 73 0751, dated July 16, 2010, 6 pages
□
EFS Web 2.1.17
INFORMATION DISCLOSURE
STATEMENT BY APPLICANT
( Not for submission under 37 CFR 1.99)
Application Number
10551504
Filing Date
2006-05-12
First Named Inventor
Tsunoda et al.
Art Unit
1647
Examiner Name
Shulamith H. Shafer
Attorney Docket Number
14875-0153US1
17
U.S. EXAMINER ELLY GERALD STOICA. USPTO Final Office Action in U.S. App. Ser. No. 11/913,229. mailed
June 10, 2010, 10 pages
□
18
U.S. EXAMINER MEERA NATARAJAN, USPTO Restriction Requirement in U.S. App. Ser. No. 11/916,351, mailed
September 3, 2010, 8 pages
□
19
European Search Report for App. Ser. No. EP 06 75 7198, dated June 11 , 2010, 2 pages
□
20
U.S. EXAMINER MISOOK YU, USPTO Restriction Requirement in U.S. App. Ser. No. 11/916,979, mailed July 1,
2010, 7 pages
□
21
Supplementary European Search Report for App. Ser. No. EP 07 74 5133, dated May 21 , 2010, 2 pages
□
If you wish to add additional non-patent literature document citation information please click the Add button Add |
EXAMINER SIGNATURE
Examiner Signature Date Considered
*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
citation if not in conformance and not considered. Include copy of this form with next communication to applicant.
1 See Kind Codes cf USPTO Patent Documents at www.USPTO.GOV or MPEP 901 .04. ^ Enter office that issued the document, by the two-letter code (WlPO
Standard ST.3). ^ For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document
Kind of document by the appropriate symbols as indicated on the document under WiPO Standard ST.1 6 If possible. ^ Applicant Is to place a checi< mark here 11
English language translation Is attached.
EFS Web 2.1.17